LEADER 04599nam 22006254a 450 001 996203982303316 005 20240418064002.0 010 $a1-281-32022-6 010 $a9786611320225 010 $a0-470-76303-5 010 $a0-470-98872-X 010 $a0-470-99420-7 035 $a(CKB)1000000000405864 035 $a(EBL)351308 035 $a(OCoLC)437218580 035 $a(SSID)ssj0000209993 035 $a(PQKBManifestationID)11912085 035 $a(PQKBTitleCode)TC0000209993 035 $a(PQKBWorkID)10283521 035 $a(PQKB)11142085 035 $a(MiAaPQ)EBC351308 035 $a(Au-PeEL)EBL351308 035 $a(CaPaEBR)ebr10236624 035 $a(CaONFJC)MIL132022 035 $a(EXLCZ)991000000000405864 100 $a20050217d2005 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aNew arrhythmia technologies$b[electronic resource] /$fedited by Paul J. Wang ... [et al.] 205 $a1st ed. 210 $aMalden, Mass. $cBlackwell Futura$d2005 215 $a1 online resource (306 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-3293-0 320 $aIncludes bibliographical references and index. 327 $aNew Arrhythmia Technologies; Contents; List of Contributors; Preface; Part I: Advances in antiarrhythmic pharmacologic therapy; 1 New antiarrhythmic pharmacologic therapies and regulatory issues in antiarrhythmic drug development; 2 New frontiers in antithrombotic therapy for atrial fibrillation; Part II: Future of antiarrhythmic therapy; 3 Principles of pharmacogenomics: Focus on arrhythmias; 4 The cardiac sodium-channel carboxy terminus: predicted and detected structure provide a novel target for antiarrhythmic drugs development 327 $a5 Embryonic stem-cell-derived cardiomyocytes as a model for arrhythmia 6 Gene and cell therapy for sinus and AV nodal dysfunction; 7 Gene therapy for cardiac tachyarrhythmias; Part III: Monitoring, noninvasive mapping, risk assessment, and external defibrillation; 8 New developments in noninvasive rhythm monitoring, implantable hemodynamic monitoring, functional status monitoring and noninvasive mapping; 9 Techniques of prediction of arrhythmia occurrence and stratification for sudden cardiac death 327 $a10 Beta-blocker efficacy in long-QT syndrome patients with mutations in the pore and nonpore regions of the hERG potassiumchannel gene 11 New developments in out-of-hospital cardiac defibrillation: evaluation of AED strategies; Part IV: Advances in pacing; 12 Sensor and sensor integration; 13 New electrode and lead designs for pacemakers; 14 Current concepts in intravascular pacemaker and defibrillator lead extraction; 15 Left ventricular epicardial lead implantation: Anatomy, techniques, and tools; 16 New resynchronization lead systems and devices; 17 New indications for pacing 327 $aPart V: Advances in implantable defibrillators 18 Implantable defibrillator sensing and discrimination algorithms; 19 Arrhythmia prevention and termination algorithms; 20 New lead designs and lead-less systems; 21 Optimization of defibrillation function; 22 Remote web-based device monitoring; 23 New ICD indications; Part VI: Advances in catheter surgical ablation; 24 Advances in surgical ablation devices for atrial fibrillation; 25 Epicardial access: present and future applications for interventional electrophysiologists; 26 Advances in catheter control devices 327 $a27 Advances in energy sources in catheter ablation28 New ablation paradigms: Anatomic ablation of complex arrhythmia substrates; Index 330 $aNew Arrhythmia Technologies provides a complete discussion of recent, emerging, and future arrhythmia technologies. This forward-thinking book details successful trials and investigates areas of research that have not yet reached the trial phase. The elite panel of authors have explored fresh information on:advances in antiarrhythmic pharmacologis therapy advances in monitoring, risk assessment, and noninvasive mapping advances in pacing therapy advances in implantable defibrillators advances in catheter and surgical ablation 606 $aArrhythmia$xTreatment$xTechnological innovations 615 0$aArrhythmia$xTreatment$xTechnological innovations. 676 $a616.1/28 701 $aWang$b Paul J$0881327 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996203982303316 996 $aNew arrhythmia technologies$92148692 997 $aUNISA